Find Articles



Return to:Arthritis Articles
Or:Recent Arthritis Articles

Nitec Pharma Licenses Tarenflurbil for Chronic Inflammation and Pain


http://www.forbes.com/businesswire/feeds/businesswire/200...

Forbes - Potential indications of Tarenflurbil include Osteoarthritis, Rheumatoid Arthritis and related diseases such as Ankylosing Spondylitis. Osteoarthritis, the most common form of arthritis, is a major cause of pain and morbidity. Its prevalence is ...



Article Finder:

November 04, 2007 09:59:00 PM
Article Directory